Markets

Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs

By The Coin Weekly
This post was originally published on this site

The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.


Latest stories

- Advertisement - spot_img

You might also like...

Stay in the Loop

Get the daily email from CryptoNews that makes reading the news actually enjoyable. Join our mailing list to stay in the loop to stay informed, for free.

The Coin Weekly — World of Crypto in One Source. Powered by Tangled Labs. Built for the Web3 curious and the crypto committed.

Tags

All rights reserved © 2025 The Coin Weekly

a{color:#000; } .etn-event-tag-list a:hover{ border-color: